• X
FreeOx
  • ABOUT
  • TEAM
  • PIPELINE
  • PARTNERSHIPS
  • NEWS
  • CONTACT US
Select Page
A preclinical trial by the U.S. National Institutes of Health validates the efficacy of Uric Acid for ischaemic stroke

A preclinical trial by the U.S. National Institutes of Health validates the efficacy of Uric Acid for ischaemic stroke

by freeoxbio-admin | Feb 15, 2023 | News

Uric Acid was shown to improve the prognosis of ischaemic stroke in a preclinical study carried out on rodents within the framework of the Stroke Preclinical Assessment Network (SPAN) in the USA, a network of experimental laboratories focusing on cerebral ischaemia,...
A study conducted at Hospital Clínic Barcelona and led by Dr Ángel Chamorro, Co-Founder and Scientific Director of FreeOx Biotech, changes the paradigm in ischaemic stroke treatment

A study conducted at Hospital Clínic Barcelona and led by Dr Ángel Chamorro, Co-Founder and Scientific Director of FreeOx Biotech, changes the paradigm in ischaemic stroke treatment

by freeoxbio-admin | Feb 17, 2022 | News

Researchers at Hospital Clínic Barcelona and the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) have shown that administration of a fibrinolytic drug after performing embolectomy in ischaemic stroke patients increases the possibilities of recovering...
FreeOx acquires the patent for the drug Ox-01 in the US for ischaemic stroke

FreeOx acquires the patent for the drug Ox-01 in the US for ischaemic stroke

by freeoxbio-admin | Oct 7, 2020 | News

FreeOx Biotech has been granted a patent for its most advanced drug, Ox-01, by the United States Patent and Trademark Office (USPTO). The patent protects the use of Ox-01 until 2038 for patients with ischaemic stroke treated with mechanical thrombectomy. “This grant...
Dr. Ángel Chamorro: “La meitat dels pacients que pateixen un ictus tornen a fer vida normal”

Dr. Ángel Chamorro: “La meitat dels pacients que pateixen un ictus tornen a fer vida normal”

by freeoxbio-admin | Oct 29, 2019 | News

En motiu del Dia Mundial de l’Ictus, el programa La nit dels ignorants de Catalunya Ràdio ha entrevistat el Dr. Ángel Chamorro, un dels principals especialistes en l’ictus, director de la Unitat Funcional de Patologia Vascular Cerebral de l’Hospital...
Dr. Ángel Chamorro: “Estamos disminuyendo las consecuencias del ictus, pero los nuevos casos crecen”

Dr. Ángel Chamorro: “Estamos disminuyendo las consecuencias del ictus, pero los nuevos casos crecen”

by freeoxbio-admin | Oct 5, 2019 | News

Entrevista del Dr. Ángel Chamorro en Misderechos.club en la cual explica los síntomas, factores de riesgo e incidencia del ictus, una patología que afecta a 17 millones de personas en todo el mundo. El Dr. Chamorro es neurólogo, director de la Unidad Funcional de...
« Older Entries
Next Entries »
  • X
© 2023 FREEOX • Terms of use • Privacy policy • Cookies policy
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}